Showing results (861-870 of 938) with videos related to

Sort By:
Pageof 94
The Journal of Physiology|November 1, 1993
Corticocortical inhibition in human motor cortexT Kujirai, M D Caramia, J C Rothwell, et al.
Annals of Neurology|April 1, 1987
Examination of motor function in lesions of the spinal cord by stimulation of the motor cortexP D Thompson, J P Dick, P Asselman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1997
Mitochondrial respiratory chain function in multiple system atrophyM Gu, M T Gash, J M Cooper, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2000
Paroxysmal dystonic choreoathetosis: clinical features and investigation of pathophysiology in a large familyP R Jarman, K P Bhatia, C Davie, et al.
British Journal of Urology|December 1, 1985
Micturition disturbance in Parkinson's diseaseH Fitzmaurice, C J Fowler, D Rickards, et al.
Experimental Neurology|March 31, 2000
Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeysT Kanda, M J Jackson, L A Smith, et al.
Synapse (New York, N.Y.)|October 25, 2000
Expression and distribution of CYP2C enzymes in rat basal gangliaA G Riedl, P M Watts, D C Douek, et al.
Biochemical Pharmacology|January 31, 1995
Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugsI Jeding, P J Evans, D Akanmu, et al.
Annals of Neurology|April 18, 1998
Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeysT Kanda, M J Jackson, L A Smith, et al.
European Journal of Pharmacology|December 15, 1992
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosetsJ W Kebabian, D R Britton, M P DeNinno, et al.
Pageof 94